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ABSTRACT
INTRODUCTION: In pa tients with colorectal can cer (CRC), pre op er a tive eval u a tion and stag ing should fo -
cus on tech niques that might al ter the pre op er a tive or intraoperative sur gi cal plan. Con ven tional im ag ing
meth ods (CT, MRI) have low ac cu racy for iden ti fy ing the depth of tu mour in fil tra tion and have lim ited abil ity 
to de tect re gional lymph node in volve ment. The aim of this study was to eval u ate the util ity of FDG-PET in the 
ini tial stag ing of pa tients with CC in com par i son with con ven tional stag ing meth ods and to de ter mine its im -
pact on ther a peu tic man age ment. METHODS: In First Clinic of Sur gery at Uni ver sity Hos pi tal “St. Ma rina”
one hun dred and four pa tients with a di ag no sis of CRC (53 males and 51 fe males; mean age 66.76± 12.36
years), se lected pro spec tively. All pa  tients were stud ied for stag ing us ing a stan dard pro ce dure (CT) and
FDG-PET. The ref er ence method was his tol ogy. The ef fect of FDG-PET on di ag no ses and the op er a tive treat -
ment was stud ied. RESULTS: In 14 pa tients, sur gery was con tra in di cated by FDG-PET ow ing to the ex tent of
dis ease (only 6/14 sus pected by CT). FDG-PET re vealed four syn chro nous tu mours. For N stag ing, both pro -
ce dures showed a rel a tively high spec i fic ity but a low di ag nos tic ac cu racy (PET 56%, CT 60%) and sen si tiv ity 
(PET 21%, CT 25%). For M as sess ment, di ag nos tic ac cu racy was 92% for FD GPET and 87% for C T.
FDG-PET re sults led to mod i fi ca tion of the ther apy ap proach in 17.85% of the pa tients with rec tal can cer and 
in 14.8% of the pa  tients with co lon can cer. CONCLUSION: Co m pared with co n ven tional tech niques,
FDGPET ap pears to be use ful in pre-sur gi cal stag ing of CC, re veal ing un sus pected dis ease and im pact ing on
the treat ment ap proach. 
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INTRODUCTION
Colorectal can cer is the third most fre quently di ag nosed
ma lig nant tu mour and the third most fre quent cause of can -
cer death in West ern coun tries. In Spain, it is the sec ond
cause of can cer death in both males (af ter lung can cer) and
fe males (af ter breast can cer) and rep re sents 11% of all can -
cer deaths [1]. The di ag no sis of colorectal car ci noma is
based on colonoscopy and bi opsy. Sur gery is the main ther -
a peu tic mo dal ity for pa tients with colorectal car ci noma,
even in those with me tas ta sis for whom pal lia tive tech -
niques may be ben e fi cial [2]. Af ter ini tial di ag no sis, ac cu -
rate stag ing is the next im por tant step in can cer man age -
ment. Pre op er a tive eval u a tion and stag ing should fo cus on
tech niques that might pre clude sur gery en tirely, al ter the
pre op er a tive or intraoperative sur gi cal plan, or in di cate the
need for pre op er a tive adjuvant ther apy [3]. Depth of pen e -
tra tion through the bowel wall, in volve ment of lymph
nodes, and pres ence of dis tant or gan metastases are prog -
nos tic fac tors in pa tients with colorectal can cer [2]. Mor -
pho log i cal pro ce dures, i.e. com puted to mog ra phy (CT) and 
mag netic res o nance im ag ing (MRI), have shown low (al -
though in creas ing) ac cu racy for iden ti fy ing the depth of tu -
mour in fil tra tion within the bowel wall in co lon car ci noma
and are of lim ited value in the de tec tion of re gional lymph
node in volve ment [2]. Nor mal-sized lymph nodes may
con tain tu mour, whereas en larged nodes may merely be re -
ac tive. There fore, for the vast ma jor ity of pa tients with
colorectal can cer, a CT or MRI ex am i na tion is not re quired
for N stag ing, which is de ter mined ac cord ing to sur gi cal
and patho log i cal cri te ria. Nev er the less, most pa tients un -
dergo a pre op er a tive CT ex am i na tion of the chest, ab do -
men and pel vis for de tec tion of met a static dis ease [2]. In
ad di tion to pro vid ing im por tant prog nos tic in for ma tion, the 
iden ti fi ca tion of dis tant metastases has been shown to ben e -
fit both the ini tial stag ing and the fol low-up of pa tients with
colorectal can cer [4]. Ac cu rate stag ing that iden ti fies un -
sus pected met a static dis ease as sists in op ti mis ing pa tient
man age ment by rul ing out sur gery in some cases and en -
sur ing an ad e quate sur gi cal ap proach in oth ers. The ben e -
fits of sur gi cal re sec tion and sys temic che mo ther apy in pro -
long ing the sur vival of pa tients with hepatic metastases
have been es tab lished in re cent years. Out comes of sur gery
in pa tients with resectable liver dis ease show 5-year sur -
vival rates of 40%, com pared with no sur vival at 5 years in
un treated pa tients [5, 6]. Cur rent strat e gies aim to in crease
the num ber of can di dates for cu ra tive hepatic re sec tion.
These strat e gies in clude the use of pre op er a tive sys temic
che mo ther apy and ab la tive ther apy, which can lead to sur -
gery with cu ra tive in tent for pa tients ini tially thought to
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have unresectable dis ease [6–8]. The key el e ment in im -
prov ing out come is pa tient se lec tion, which re quires care ful 
as sess ment of the pre cise lo ca tion and ex ten sion of hepatic
metastases and the ex clu sion of pa tients with unresectable
extrahepatic dis ease. The pre op er a tive dem on stra tion of
wide spread met a static dis ease will pre clude sur gery in
some pa tients, thereby avoid ing op er a tive mor bid ity if the
pri mary tu mour is asymp tom atic and does not cause ob -
struc tion [6]. Fluoro-2-deoxy-D-glu cose (FDG) is a glu -
cose an a logue that is phosphorylated in the cells but is not
fur ther me tabo lised. Most ma lig nant tu mours show in -
creased up take of FDG, be cause ma lig nant trans for ma tion
and tu mour cell growth are as so ci ated with overexpression
of glu cose trans port ers and in creased hexokinase ac tiv ity
[9].
Many stud ies have re ported the value of pos i tron emis sion
to mog ra phy (PET) with FDG in the as sess ment of var i ous
ma lig nant pri mary and re cur rent tu mours [10, 11], in clud -
ing re cur rent and met a static colorectal can cers [10–12]. In
pa tients with the lat ter, FDG-PET ap pears to be more sen si -
tive than ul tra sound, CT or MRI for the de tec tion of liver
metastases [13], and ad di tional dis ease sites are iden ti fied
in up to 23% of pa tients [14]. How ever, the lit er a ture on the 
per for mance of FDG-PET in the ini tial stag ing of
colorectal can cer is lim ited [15–17] and based on a small
num ber of pa tients, re strict ing our abil ity to draw de fin i tive
con clu sions about the util ity of this tech nique in the stag ing
of N, M or even T (in syn chro nous tu mour cases) sta tus.
The aim of this study was to com pare the di ag nos tic ac cu -
racy of FDG-PET with that of con ven tional stag ing meth -
ods in the ini tial stag ing of pa tients with colorectal car ci -
noma and to de ter mine the re per cus sions of this tech nique
for ther a peu tic man age ment.
MATERIALS AND METHODS
The pa tients in this study have re ferred to First Clinic of
Sur gery at Uni ver sity Hos pi tal “St. Ma rina” with a
histological di ag no sis of colorectal car ci noma be tween
May 2008 and Sep tem ber 2010 and were stud ied fol low ing 
the stand ard ised pro to col for stag ing and es tab lish ing the
most ad e quate treat ment. This pro to col con sisted of: (a)
clin i cal anamnesis, (b) haema to logi cal anal y ses, (c) CT of
the ab do men and the tho rax (d) endorectal ul tra sound in
cases of can cer of the lower mid dle third of the rec tum, (e)
whole-body FDG-PET. All pa tients were se lected for elec -
tive sur gery with post op er a tive adjuvant che mo ther apy or
pal lia tive che mo ther apy, de pend ing on the stage of the dis -
ease.Pa tients with rec tal tu mour un der went rad i cal sur gery
with to tal ex ci sion of the mesorectum when tu mours were
lo cated in the mid dle or lower thirds. Patho log i cal study of
the pri mary tu mour and adenopathies was per formed on
par af fin-em bed ded sec tions stained with
haematoxylin-eosin. The most rel e vant im pact on the sur -
gi cal man age ment of these pa tients de rives from the de tec -
tion of un sus pected tu mour spread. This event has a prev a -
lence of 20% [6, 18]. FDG-PET/CT would in crease the de -
tec tion sen si tiv ity up to 90%, ac cord ing to some au thors
[19].
One hun dred and four con sec u tive pa tients from the First
Clinic of Sur gery with a histological di ag no sis of colorectal 
car ci noma were en rolled in this pro spec tive study: 53
males and 51 fe males aged from 28 to 83 years (mean age
66.76 years). 
Ex clu sion cri te ria were: 
• presence of other tumour disease, 
• history of abdominal surgery, 
• pregnancy orbreast-feeding,
• refusal to participate. 
At the time of pre op er a tive di ag no sis, tu mours were lo cated 
in the rec tum (n=56), sig moid co lon (n=20), as cend ing co -
lon (n=2), trans verse co lon (n=6), de scend ing co lon (n=4),
caecum (n=10) and splenic flex ure (n=6). The large num -
ber of rec tal car ci no mas may have been caused by the ad -
mis sion of pa tients from cen tres that do not of fer sur gi cal
treat ment of this type of tu mour. 
CT-STUDY
All CT scans were per formed with a Siemens Somatom
Dou ble Source spi ral scan ner af ter ad min is tra tion of oral
and in tra ve nous con trast. Re ports were re viewed for the
pres ence of masses in the co lon or rec tum, re gional lymph
node in volve ment, ab dom i nal lymph node in volve ment,
and dis tant me tas ta sis. Re gional lymph nodes of 1 cm or
larger were scored as pos i tive N, and other site ab nor mal i -
ties in ter preted as prob a ble met a static dis ease were scored
as M dis ease. 
FDG-PET STUDY
Af ter ad min is tra tion of 370 MBq 18F-FDG whole-body
PET-scan was per formed. 5-min emis sion study was per -
formed for each bed po si tion, in clud ing the head, chest, ab -
do men and pel vis; im me di ately af ter the emis sion stud ies, a 
3-min trans mis sion scan was per formed for each bed po si -
tion. Im age pro cess ing and re con struc tion were per formed
on a SUN com puter Work sta tion (SUN Microsystem,
Moun tain View, CA, USA). Im ages were qual i ta tively
ana lysed and clas si fied as pos i tive or neg a tive for ma lig -
nancy by the sub jec tive anal y sis of a sin gle phy si cian with
ex pe ri ence of PET, con sid er ing the pres ence of in creased
(mod er ate or in tense) glu cose up take as pos i tive for ma lig -
nancy (tak ing into con sid er ation the nor mal biodistribution
of the tracer). Semi-quan ti ta tive anal y sis was si mul ta -
neously per formed by cal cu lat ing the stand ard ised up take
value (SUV) of prob lem ar eas, us ing the slice with max i -
mum count den sity: SUV=(in jected dose cor rected by dis -
in te gra tion/ac tiv ity con cen tra tion)/(in jected dose/body
weight). A max i mal SUV >2.5 was con sid ered pos i tive for
tu mour ac tiv ity. This cut off point was for guid ance pur -
poses only, how ever, and the de fin i tive re port was pre dom -
i nantly based on qual i ta tive anal y sis. 
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DATA ANALYSIS
The di ag nos tic va lid ity of the two pro ce dures in N and M
stag ing was ana lysed by com par ing the in for ma tion in the
re ports of each ex am i na tion with the ref er ence cri te ria,
solely con sid er ing N0-N+ and M0-M+ cat e go ries.
FDG-PET and CT find ings were con firmed as fol lows: (a)
by patho log i cal study (b) by sur gi cal ex plo ra tion and bi -
opsy; (c) in the case of ex tra-ab dom i nal metastases, by
patho log i cal study af ter bi opsy or (when pa thol ogy was not 
avail able) by clin i cal fol low-up for at least 1 year or by CT
study af ter at least 2 months dem on strat ing le sion growth
(>0.5 cm) in com par i son with the ini tial ex am i na tion; or (d) 
in cases of death, by au topsy ex am i na tion. Pa thol ogy or au -
topsy ma te rial was re viewed in 90 out of the 104 pa tients
and clin i cal find ings and sub se quent im ag ing stud ies were
re viewed in 14 out of the 104 pa tients to cre ate a fi nal TNM 
stag ing ac cord ing to the Amer i can Joint Com mit tee on
Can cer (TNM stag ing sys tem) [20]. Sta tis ti cal anal y sis was 
per formed us ing Microsoft Of fice Ex cel to de ter mine the
sen si tiv ity, spec i fic ity, pos i tive and neg a tive pre dic tive val -
ues.
RESULTS
From 104 pa tients with histologically con firmed colorectal
car ci noma af ter ap pli ca tion of the di ag nos tic pro to col con -
tra in di ca tions for sur gi cal treat ment were found in 14 of
them. These patients did not un dergo sur gi cal treat ment be -
cause its ap pli ca tion was con tra in di cated by the ex tent of
the dis ease. Of these pa tients, four had mul ti ple
unresectable hepatic le sions, two showed lymph node in -
volve ment, three had both of the afore men tioned con di -
tions, two had hepatic and lung metastases, one pa tient in
stage IV had a hepatic me tas ta sis that was only po ten tially
unresectable but re fused any type of treat ment; one had no
find ings that con tra in di cated sur gery but showed peritoneal 
spread at laparotomy and, fi nally, one had a func tional sta -
tus that was in ad e quate for sur gery de spite hav ing a
resectable pri mary le sion. These pa tients were re ferred to
the On col ogy De part ment for adjuvant or pal lia tive ra dio -
ther apy and/or che mo ther apy or were re ferred to the Pal lia -
tive Care De part ment. In these 14 pa tients, CT (6/14)
and/or FDG-PET (14/14) showed the pres ence of
extraregional lym phatic spread or dis tant metastases, which 
were con firmed by se lec tive bi op sies of prob lem ar eas in
the De part ment of Im age Di ag nos tics. Histological study of 
the pri mary le sions gave the fol low ing re sults: 59 mod er -
ately dif fer en ti ated adenocarcinomas, 31 well-dif fer en ti -
ated adenocarcinomas, two poorly dif fer en ti ated
adenocarcinomas, ten mod er ately dif fer en ti ated mucinous
adenocarcinomas and two well-dif fer en ti ated mucinous
adenocarcinomas. 
Both CT and FDG-PET showed changes at the level of the
pri mary le sion that were com pat i ble with tu mour sta tus.
Most pri mary tu mours showed in creased FDG up take, with 
in tense tracer ac cu mu la tion in 92 cases, mod er ate ac cu mu -
la tion in 11 cases and no sig nif i cant up take in one case
(small well-dif fer en ti ated mucinous adenocarcinoma).
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FDG-PET re vealed syn chro nous tu mours in four pa tients:
mod er ately dif fer en ti ated adenocarcinoma and sev eral
other small le sions in the sig moid co lon; mod er ately dif fer -
en ti ated adenocarcinomas in the sig moid co lon and splenic
an gle; mod er ately dif fer en ti ated adenocarcinomas in the
sig moid co lon and trans verse co lon; and poorly dif fer en ti -
ated adenocarcinomas in the rec tum and sig moid co lon.
These syn chro nous le sions were not di ag nosed by en dos -
copy be cause it was im pos si ble to pass through the pri mary
le sion (adult and pae di at ric en do scope) and they were only
sus pected in one case on the ba sis of CT find ings and con -
trast en ema study. Lym phatic spread was stud ied in the 90
pa tients who un der went sur gery (for whom there was
there fore a pa thol ogy re port), eval u at ing only the pres ence
or ab sence of in volved lymph nodes (i.e. N0 or N+). CT
cor rectly de tected the pres ence/ab sence of lymph node in -
volve ment in 54 pa tients, with 36 false neg a tive and two
false pos i tive re sults. FDG-PET cor rectly de tected the pres -
ence/ab sence of lymph node in volve ment in 50 pa tients,
with 38 false neg a tive and 2 false pos i tive re sults. The di ag -
nos tic va lid ity of the two pro ce dures (in a pop u la tion with a 
prev a lence of locoregional lymph node tu mour dis ease of
53%) is re ported in Ta ble 2. 
Both pro ce dures showed a rel a tively high spec i fic ity but a
rel a tively low over all di ag nos tic ac cu racy (PET 56%, CT
60%) and sen si tiv ity (PET 21%, CT 25%). In the M stag -
ing, CT plus chest X-ray cor rectly clas si fied 90 of the 104
pa tients, with ten false neg a tives and four false vol u met ric
pro jec tion and a hypermetabolic up take at the left ileac
fossa cor re spond ing to a sigma tu mour. No other foci were
ob served that sug gested lymph nodes or dis tant metastases
positives, while FDG-PET cor rectly clas si fied 96 of the pa -
tients, with two false neg a tives and six false positives. The
di ag nos tic ac cu racy of the pro ce dures (for a pop u la tion
with a prev a lence of met a static dis ease of 17%) is re ported
in Ta ble 3, show ing an over all di ag nos tic ac cu racy of 92%
for FDG-PET and 87% for CT plus chest X-ray. 
The post-sur gi cal histological ex am i na tion of lymph nodes
showed that 45 pa tients were in stage N0, 29 in stage N1
and 16 in stage N2. The de fin i tive stag ing of the 104 pa -
tients was as fol lows: 20 pa tients in stage I, 22 in stage II, 34 
pa tients in stage III (4 IIIA, 16 IIIB and 14 IIIC) and 28 in
stage IV. The con tri bu tion of FDG-PET is shown in de tail
in Ta bles 1 and 4. 
FDG-PET mod i fied the ini tial ther a peu tic ap proach (from
sur gery to ra dio/che mo ther apy) in seven out of the sub -
group of 14 pa tients who did not un dergo sur gery.
FDG-PET re vealed patho log i cal de pos its un de tected by
con ven tional di ag nos tic meth ods in 19.2% of pa tients (11
non-op er ated pa tients, six op er ated pa tients and three pa -
tients with un sus pected syn chro nous tu mours). FDGPET
changed the stag ing of the dis ease in 13.46% of pa tients
(seven non-op er ated and seven op er ated). FDG-PET
changed the ther a peu tic ap proach in 17.85% of the pa tients
with rec tal can cer and 14.8% of the pa tients with co lon can -
cer (12/56; five non-op er ated pa tients, four op er ated pa -
tients and three pa tients with a syn chro nous tu mour). 
DISCUSSION
The ob jec tive of pre op er a tive stag ing is to iden tify the ex -
tent of lo cal in fil tra tion, the de gree of lymph node in volve -
ment and the pres ence of hepatic or dis tant metastases. Cor -
rect stag ing al lows treat ment to be planned, in clud ing sur -
gery, pal lia tive che mo ther apy or ad di tional treat ments such 
as neoadjuvant ra dio- or che mo ther apy. This pro spec tive
study in cluded 104 con sec u tive pa tients with colorectal
car ci noma un der go ing ther apy dur ing the study pe riod. CT
and PET were both used, in a stand ard ised pre op er a tive di -
ag nos tic pro ce dure, and these two mo dal i ties were com -
pared. Ref er ence stan dard was patho log i cal stag ing in
91.5% of cases and oncological fol low-up pro to col in clud -
ing im ag ing anal y sis and clin i cal ex am i na tion in the re -
main ing 8.5%. In the pres ent pa per, colorectal can cer is
con sid ered as a sin gle en tity, com prised of two dif fer ent
types of can cer, but both re quir ing fur ther di ag nos tics and
re-stag ing. In the T stag ing of the colorectal can cers, the
im ag ing tech niques did not al low eval u a tion of the de gree
of in fil tra tion of the in tes ti nal wall by the tu mour [2], which 
was de ter mined by intraoperative ob ser va tion and
histopathological study of the spec i men. The lack of ref er -
ence an a tom i cal struc tures and its lim ited spa tial res o lu tion
makes FDG-PET es pe cially in ad e quate in fur nish ing pre -
cise in for ma tion for lo cal stag ing, and it only of fers use ful
data in cases of gross pen e tra tion with in va sion of ad ja cent
struc tures. In rec tal tu mours, only endorectal ul tra sound
shows good sen si tiv ity and spec i fic ity in the de tec tion of
muscularis propria and perirectal tis sue in va sions [21, 22].
In the pres ent study, FDG-PET cor rectly de tected all pri -
mary tu mours, iden ti fy ing four syn chro nous tu mours that
had not been local ised in the pre op er a tive en do scopic
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study, al though it did not pro vide in for ma tion on the de gree 
of infiltration of the in tes ti nal wall. FDG-PET stud ies are
not rec om mended in cur rent clin i cal prac tice for the di ag -
no sis of colorectal can cers or to eval u ate their in fil tra tion
[20]. Nev er the less, the iden ti fi ca tion of fo cal up take of
FDG in the co lon should not be ig nored, re gard less of the
clin i cal set ting, since it may cor re spond to a ma lig nant le -
sion, as in the case of the four syn chro nous tu mours de -
tected in our se ries. In more than three-quar ters of pa tients
with colorectal can cer, the dis ease is lim ited to the in tes tine
or to re gional pericolic or mesenteric lymph nodes at the
time of di ag no sis [2]; there fore, most sur gery of colorectal
can cer is per formed with cu ra tive in tent. N stag ing re quires
the count ing of pericolic and mesenteric lymph nodes. In
colorectal car ci noma, re gional lymph nodes are fre quently
small and found close to the pri mary tu mour. 
More over, pericolic nodes are of ten small, con tain ing a
small num ber of tu mour cells that are only ob serv able in
immunohistochemical study [2]. The lo cal isa tion of lym -
phatic dis ease is dif fi cult us ing im ag ing tech niques only.
De spite the iden ti fi ca tion of lymph nodes as small as 2–3
mm in high-res o lu tion spa tial im ages us ing
multidetector-row spi ral CT, the re li able de tec tion of
metastases to lymph nodes re mains im pos si ble, as the de -
tec tion is re lated to the size of the nodes [23]. The draw back 
of mor pho log i cal im ages is that it is dif fi cult to dis tin guish
met a static from re ac tive nodes even in case of large lymph
nodes and to de tect small micrometastatic. The high fre -
quency of micrometastasis in nodes of nor mal size is typ i -
cal for CRC in com par i son to other tu mors[24]. There is a
wide vari a tion in the re ported sen si tiv ity of endorectal ul -
tra sound (62–83%) and CT (22–73%) in the de tec tion of
lym phatic in volve ment, and MRI does not have better ef -
fect (39–95%) due to its vol u met ric lim i ta tion of the di ag -
nos tic field [25]. In this study, CT and FDG-PET showed
equally poor sen si tiv ity in the de tec tion of re gional lymph
nodes and in the eval u a tion of the num ber in volved, with
val ues of 21% for FDG-PET and 25% for CT. Nev er the -
less, FDG-PET was ap pre cia bly su pe rior to CT in the iden -
ti fi ca tion of met a static dis ease, with a sen si tiv ity of 89% for 
FDG-PET ver sus 44% for CT. These find ings are in agree -
ment with re ports by other au thors [15–17]. The lo cal isa -
tion of lym phatic in volve ment is de ter mined not only by
the size of nodes (in re la tion to the res o lu tion of the scan -
ner) on the met a bolic im age with FDG but also by the pres -
ence of tu mour in volve ment and its cell load. One ex pla na -
tion for the low sen si tiv ity of FDG-PET in the de tec tion of
in volved lymph nodes may be their prox im ity to the pri -
mary tu mour and blad der, in which the
radiopharmaceutical phys i o log i cally ac cu mu lates. The ap -
pli ca tion of uri nary catheterization and di uret ics may ben e -
fit the in ter pre ta tion of the im age, but this is not the sub ject
of the pres ent study. The pres ence of ex tra-re gional lymph
node metastases in creases the stage of the dis ease to IV
stage. CRC metastasize via the lym phatic sys tem. The
haematogenous spread of colorectal car ci noma can also in -
volve (usu ally step by step) the liver, lungs and, to a lesser
de gree, bone, brain and other sites [18]. The most rel e vant
con tri bu tion of the pro posed pro ce dure is the iden ti fi ca tion
of met a static dis ease. Hepatic metastases are found in
10–25% of pa tients at ini tial sur gery, and 25% of these are
can di dates for re sec tion [2]. In the pres ent se ries, 28 pa -
tients (26.9%) were in stage IV. CT had a sen si tiv ity of
44% and a spec i fic ity of 95% in the di ag no sis of met a static
dis ease, and it de tected a pa tient with retroperitoneal lymph
node in volve ment, while FDGPET showed a sen si tiv ity of
89% and a spec i fic ity of 93% and re vealed that six pa tients
had un sus pected extrahepatic met a static in volve ment,
mainly in the form of ab dom i nal lymph node in volve ment
and lung metastases. 
These data are sim i lar to those re ported in pre vi ous stud ies
[15–17] and con firm the ad di tional value of FDG-PET,
com pared with CT, in the pre op er a tive as sess ment of can -
di dates for cu ra tive hepatic re sec tion of colorectal
metastases [26, 27]. Re gard less of the sen si tiv ity and spec i -
fic ity of FDG-PET for the de tec tion of hepatic metastases,
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it does not pro vide suf fi cient an a tom i cal in for ma tion for
ad e quate sur gi cal plan ning. Be sides the pres ence or not of
me tas ta sis, knowl edge of its pre cise lo ca tion is re quired to
plan the ap pro pri ate sur gi cal ap proach or even to ex clude
sur gery. In this con text, CT plays a com ple men tary role in
the eval u a tion of these pa tients. It is ex pected that new hy -
brid PET-CT equip ment will sub stan tially change this sit u -
a tion, with con sid er able im prove ments in di ag nos tic va lid -
ity com pared with that of fered by sep a rate FDG-PET and
CT ex am i na tions [28]. How ever, a sur gi cal ap proach to
hepatic dis ease re quires extrahepatic met a static dis ease to
be ruled out, and it is here that FDG-PET shows its great est
value. In the pres ent se ries, extrahepatic met a static sites not
de tected by other tech niques were found in 6.73% of the
pa tients, lead ing to a change in the ther a peu tic strat egy.
There was a change in ther a peu tic ap proach in 25% of the
pa tients with po ten tially resectable hepatic metastases. Var -
i ous stud ies have also as sessed the ad di tional value of
FDG-PET com pared with CT in these pa tients, find ing that
PET of fers more in for ma tion over the pro vided by CT and
that this in for ma tion of ten af fects the treat ment. Some au -
thors found that when FDG-PET is ad di tional method to
CT in the pre op er a tive plan ning of pa tients with hepatic
metastases as ad di tional extrahepatic dis ease sites were
iden ti fied in 11–23% of cases [14, 29, 30]. Iden ti fi ca tion of
such sites fre quently leads to a change in ap proach from
sur gery to sys temic che mo ther apy. The sen si tiv ity and
spec i fic ity of FDG-PET for the de tec tion of dis ease can be
af fected by var i ous fac tors. False pos i tive re sults have been
re ported in in flam ma tion set tings, such as hepatic ab -
scesses, di ver tic u li tis and ac tive granulomatous dis ease
[22]. Phys i o log i cal ac tiv ity in the nor mal in tes tine and gen -
i to uri nary sys tem can also ham per the cor rect in ter pre ta tion 
of cer tain up take ar eas. Ac cord ing to our ex pe ri ence, it is
de sir able to per form blad der catheterisation and to ad min is -
ter di uret ics be fore the ex am i na tion in or der to avoid ac cu -
mu la tion of urine, con tain ing the radiopharmaceutical, in
the blad der. False neg a tives can be pro duced by tu mours
with low met a bolic ac tiv ity such as mucinous
adenocarcinomas, or by small le sions, micrometastatic dis -
ease [22] or the pres ence of patho log i cal lymph nodes in
the im me di ate vi cin ity of the pri mary tu mour. The cor rect
an a tom i cal lo cal isa tion of 18F-FDG de pos its can im prove
their in ter pre ta tion, and it is hoped that new PET-CT scan -
ners, per mit ting the re cord ing of both an a tom i cal and met a -
bolic in for ma tion, will en hance the re li abil ity of im ag ing
stud ies [22]. In this study, FDG-PET changed the tu mour
stag ing in 13.46% of pa tients, mod i fied the scope of sur -
gery in 11.54% and led to a change in the ther a peu tic ap -
proach in 17.85% of those pa tients with colorectal can cer.
These changes were largely based on the di ag no sis of pre -
vi ously un sus pected tu mour ac tiv ity, i.e. of syn chro nous
tu mours and hepatic and extrahepatic metastases that had
not been de tected by con ven tional stag ing stud ies. There -
fore, FDG-PET ap pears to be highly use ful in pa tients with
ev i dence of resectable hepatic me tas ta sis ac cord ing to the
stage, pro vided by con ven tional tech niques, and of less
util ity in the re main der of the pa tients. Cost-ef fi ciency and
cost-ef fi cacy stud ies, the cri te ria for se lec tion of pa tients
and the in flu ence of this method on the sur viv abil ity in the
dif fer ent stages of the dis ease.
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